![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Intellia Therapeutics Inc | NASDAQ:NTLA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.855 | 3.29% | 26.865 | 26.86 | 26.88 | 27.1099 | 25.92 | 26.36 | 871,746 | 18:19:44 |
CUSIP No. 45826J105
|
||||
1
|
NAME OF REPORTING PERSONS
OrbiMed Advisors LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) ☐
(b) ☐
|
|||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
2,113,000
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
2,113,000
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,113,000
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) |
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.99%*
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IA
|
CUSIP No. 45826J105
|
||||
1
|
NAME OF REPORTING PERSONS
OrbiMed Capital GP V LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) ☐
(b) ☐
|
|||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
1,650,100
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
1,650,100
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,650,100
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) |
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.90%*
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
OO
|
CUSIP No. 45826J105
|
||||
1
|
NAME OF REPORTING PERSONS
OrbiMed Global Healthcare GP LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
☐
(b)
☐
|
|||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
462,900
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
462,900
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
462,900
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) |
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.09%*
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
OO
|
Item 1. |
Security and Issuer
|
Item 2. |
Identity and Background
|
Item 3. |
Source and Amount of Funds or Other Consideration
|
Item 4. |
Purpose of Transaction
|
Item 5. |
Interest in Securities of the Issuer
|
Seller
|
Date of Transaction
|
Transaction
|
Number of Shares
|
Price Per Share*
|
OPI V
|
January 30, 2018
|
Sold
|
73,888
|
$25.87
|
OGH
|
January 30, 2018
|
Sold
|
33,796
|
$25.87
|
OPI V
|
February 7, 2018
|
Sold
|
68,300
|
$25.76
|
OGH
|
February 7, 2018
|
Sold
|
31,700
|
$25.76
|
OPI V
|
February 14, 2018
|
Sold
|
11,600
|
$25.76
|
OGH
|
February 14, 2018
|
Sold
|
5,400
|
$25.76
|
Item 6. |
Contracts, Arrangements, Understandings or Relationship with Respect to Securities of the Issuer
|
Item 7. |
Materials to Be Filed as Exhibits
|
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP V LLC, and OrbiMed Global Healthcare GP LLC.
|
|
OrbiMed Advisors LLC
|
|
||
|
|
|
||
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
Name:
|
Jonathan T. Silverstein
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
By:
|
/s/ Sven H. Borho
|
||
|
Name:
|
Sven H. Borho
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
||
|
By:
|
/s/ Carl L. Gordon
|
||
|
Name:
|
Carl L. Gordon
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
OrbiMed Capital GP V LLC
|
|
||
|
|
|
|
|
|
By:
|
OrbiMed Advisors LLC
its Managing Member
|
||
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
Name:
|
Jonathan T. Silverstein
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Sven H. Borho
|
||
|
Name:
|
Sven H. Borho
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Carl L. Gordon
|
||
|
Name:
|
Carl L. Gordon
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
OrbiMed
Global Healthcare GP LLC
|
|||
|
|
|
||
|
By:
|
OrbiMed Advisors LLC
its Managing Member
|
||
|
|
|
||
|
|
|
||
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
Name:
|
Jonathan T. Silverstein
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
||
|
By:
|
/s/ Sven H. Borho
|
||
|
Name:
|
Sven H. Borho
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
|
|
||
|
By:
|
/s/ Carl L. Gordon
|
||
|
Name:
|
Carl L. Gordon
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
Name
|
Position with Reporting
Person |
Principal Occupation
|
Samuel D. Isaly
|
Managing Member
|
Managing Member
OrbiMed Advisors LLC |
Carl L. Gordon
|
Member
|
Member
OrbiMed Advisors LLC |
Sven H. Borho
German and Swedish Citizen |
Member
|
Member
OrbiMed Advisors LLC |
Jonathan T. Silverstein
|
Member
|
Member
OrbiMed Advisors LLC |
W. Carter Neild
|
Member
|
Member
OrbiMed Advisors LLC |
Geoffrey C. Hsu
|
Member
|
Member
OrbiMed Advisors LLC |
Evan D. Sotiriou
|
Chief Financial Officer
|
Chief Financial Officer
OrbiMed Advisors LLC |
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP V LLC, and OrbiMed Global Healthcare GP LLC.
|
1 Year Intellia Therapeutics Chart |
1 Month Intellia Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions